ABEO R&D to Revenue
Abeona Therapeutics Inc · R&D to Revenue
ABEO R&D to Revenue
Latest reported44.12%period ending
ABEO Quarterly R&D/Revenue (166.67% → 44.12%)
Latest values, visible window
High-resolution chart · PNG
ABEO r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 44.1213% | |
| 109.5757% | |
| 123.8376% | |
| 0% | |
| 1,485.75% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 243.5143% | |
| 0% | |
| 9,223.5294% | |
| 0% | |
| 665.8% | |
| 3,447.6879% | |
| 427.7333% | |
| 0% | |
| 0% | |
| 0% | |
| 308.1% | |
| 113.8429% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -489.1917% | |
| 769.4558% | |
| 2,868.1159% | |
| 1,537.0998% | |
| 2,653.9535% | |
| 1,496.347% | |
| 2,676.4977% | |
| 1,181.7204% | |
| 1,186.3281% | |
| 1,491.8478% | |
| 1,410.2804% | |
| 789.3617% | |
| 1,031.1628% | |
| 554.7368% | |
| 216.3121% | |
| 175.5814% | |
| 14.9573% | |
| 30.9322% | |
| 32.7935% | |
| 69.2308% | |
| 79.0123% | |
| 124.8677% | |
| 42.1842% | |
| 26.3889% | |
| 29.6223% | |
| 35.3617% | |
| 94.7826% | |
| 52.5067% | |
| 189.1304% | |
| 102.1134% | |
| 701.9868% | |
| 746.6667% | |
| 429.2517% | |
| 944.0945% | |
| 698.0952% | |
| 770.5882% | |
| 795.1923% | |
| 389.5833% | |
| 923.8095% | |
| 1,675.6098% | |
| 682.4324% | |
| 2,731.9149% | |
| 893.1818% | |
| 25,381.5789% | |
| 2,098.0392% | |
| 9,933.3333% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 135.5694% | |
| 172.9958% | |
| 578.3133% | |
| 850.9677% | |
| 574.6377% | |
| 760% | |
| 1,883.8235% | |
| 5,720% | |
| 744.2308% | |
| 11,400% | |
| 219.1801% | |
| 457.2519% | |
| 267.2083% | |
| 2,396.7033% | |
| 650.5703% | |
| 1,140.5172% | |
| 7,672.7273% | |
| 11,772.7273% |